Mechanistic comparison of Carboxin and Secologanin Tryptamine Alkaloids Compounds formed by condensation of secologanin with tryptamine resulting in based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
9
Shared Targets
39%
Jaccard Similarity
35%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Carboxin and Secologanin share 9 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.391 means 39% of the combined target set is bound by both compounds. The IDF-weighted score of 0.347 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Carboxin and Secologanin have in common?
Carboxin and Secologanin share 9 molecular targets with a Jaccard similarity of 39%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Carboxin and Secologanin be combined?
Carboxin and Secologanin share 9 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Carboxin or Secologanin?
In the BiohacksAI corpus: Carboxin has 174 PubMed-indexed studies, Secologanin has 300 studies.